- Home
- HRTX vs QUAD Comparison
HRTX vs QUAD Comparison
Compare HRTX & QUAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRTX
- QUAD
- Stock Information
- Founded
- HRTX 1983
- QUAD 1971
- Country
- HRTX United States
- QUAD United States
- Employees
- HRTX N/A
- QUAD N/A
- Industry
- HRTX Biotechnology: Pharmaceutical Preparations
- QUAD Publishing
- Sector
- HRTX Health Care
- QUAD Consumer Discretionary
- Exchange
- HRTX Nasdaq
- QUAD Nasdaq
- Market Cap
- HRTX 325.0M
- QUAD 300.1M
- IPO Year
- HRTX 1987
- QUAD 2010
- Fundamental
- Price
- HRTX $1.88
- QUAD $5.83
- Analyst Decision
- HRTX Strong Buy
- QUAD Strong Buy
- Analyst Count
- HRTX 2
- QUAD 2
- Target Price
- HRTX $5.50
- QUAD $9.45
- AVG Volume (30 Days)
- HRTX 2.1M
- QUAD 364.5K
- Earning Date
- HRTX 05-06-2025
- QUAD 07-29-2025
- Dividend Yield
- HRTX N/A
- QUAD 5.15%
- EPS Growth
- HRTX N/A
- QUAD N/A
- EPS
- HRTX N/A
- QUAD N/A
- Revenue
- HRTX $148,518,000.00
- QUAD $2,646,800,000.00
- Revenue This Year
- HRTX $12.60
- QUAD N/A
- Revenue Next Year
- HRTX $13.66
- QUAD N/A
- P/E Ratio
- HRTX N/A
- QUAD N/A
- Revenue Growth
- HRTX 12.43
- QUAD N/A
- 52 Week Low
- HRTX $1.04
- QUAD $4.06
- 52 Week High
- HRTX $3.93
- QUAD $9.13
- Technical
- Relative Strength Index (RSI)
- HRTX 44.20
- QUAD 55.33
- Support Level
- HRTX $1.82
- QUAD $5.12
- Resistance Level
- HRTX $1.93
- QUAD $6.10
- Average True Range (ATR)
- HRTX 0.11
- QUAD 0.25
- MACD
- HRTX -0.01
- QUAD 0.01
- Stochastic Oscillator
- HRTX 36.73
- QUAD 71.00
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
About QUAD Quad Graphics Inc
Quad/Graphics Inc provides print and marketing services to help customers market their products, services, and contents. The company operates in the commercial segment of the printing industry. It operates through three divisions. The United States print and related services segment consists of the company's American operations. Besides the complete set of print and marketing solutions, this segment also manufactures ink. The international segment includes the company's printing business in Europe and Latin America and others countries. The corporate segment is engaged in the general and administrative activities as well as associated costs. The company almost generates all its revenue from the American domestic market..